Kheiron Medical

Kheiron is a UK-based startup specializing in AI and healthcare with a mission to revolutionize cancer diagnostics through the power of deep learning. The company, founded in 2016, aims to assist breast cancer patients in living longer, better lives by enabling earlier detection. Kheiron utilizes advanced deep learning methods, data science, and radiology insights to aid doctors in detecting malignancies in mammograms.

According to external clinical trial results, Kheiron’s deep learning technology is at the cutting edge of malignancy detection support in breast cancer screening. The company is poised to receive European regulatory approval in the near future. Notably, it was recently honored with the UK Government’s new AI award.

The startup's last investment was a Convertible Note investment in August 2020, with the backing of 7percent Ventures. This support will likely fuel Kheiron’s further growth and innovation in the critical intersection of AI and healthcare.